July 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan ~1 min.According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....
March 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation ~2 min.Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....
March 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results ~2 min.Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....
March 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry ~1 min.Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....
March 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry ~2 min.Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....
March 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry? ~2 min.Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....
March 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study ~1 min.Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....
February 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion ~1 min.Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....
February 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development ~1 min.Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....
February 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings ~2 min.ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....
April 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.52% Profit ~1 min.QuantWave, an automated forecasting platform, successfully predicted the short movement for REGENERON PHARMACEUTICALS, INC. with a price target of 572.6 $ on 2025-04-04, achieving a profit of 16.52%....
August 19, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 14.57% Profit Margin ~1 min.On July 2nd, 2024, QuantWave issued a forecast signal for REGENERON PHARMACEUTICALS, INC., predicting a long position when the stock was trading at 1041.78 $....
April 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with a Profit of 17.63% ~1 min.REGENERON PHARMACEUTICALS, INC. stock successfully reached the price target forecasted by QuantWave on April 4, 2025. The forecast signal was given on February 4, 2025, at a price of 695....
July 30, 2024QuantWave Achieves 17.27% Profit Target for VERTEX PHARMACEUTICALS INCORPORATED ~1 min.QuantWave, the automated forecasting platform, has successfully hit its price target forecast for VERTEX PHARMACEUTICALS INCORPORATED, resulting in a profitable return of 17.27%....
October 31, 2024REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target With 17.54% Profit ~1 min.REGENERON PHARMACEUTICALS, INC. has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 17.54%....
